LIU Bao-Jun. Identification and quantitation of platelet activating factor (PAS) in the blood and the skin of psoriatic patients and its clinical significance[J].Chinese Journal of Dermatology, 1992, 25(4): 232-234.
[1] Snyder F. Biochemistry of platdet activating factor: a unique class of biologically active phospholipids.Pro Sco Exp Med, 1989, 190:125.
[2] Cunningham FM, et al. The production of platelet activating factor (PAF) by human epidermal cells. Br J Pharmcol, 1987, 90: 117.
[3] Mallet AI, et al. Structural identification of platelet activating factor in psoriatic scale. Biochem Biophy Res Commun, 1985, 126: i92.
[4] Billah MM, et al. Identification of phospholipid platelet activating factor in human amniotic fluid and urine. Biochem Biophy Res Commun, 1983, 113: 51.
[5] Benveniste J. Advaaces in prostaglandin, throm-boxane, and leukotriene research. Vol 19. New York: Raven Press, Ltd, 1989: 355-358.
[6] Archer GB, et al. Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. Br,J Dermatol, 1985, 112: 285.